how to microdose compounded semaglutide THE GLP-1 MICRODOSING PROGRAM microdose compounded semaglutide with glycine

Pheomelanin Humans produce two pigments, and they behave completely differently: 1

L.MonnahanC

Despite how common GLP-1 use has become, there has been relatively little dermatology-focused research on their cutaneous side effects, with most of the existing literature limited to individual case reports. For the cross-sectional analysis, Fat and colleagues compared cutaneous adverse events reported in the FDA Adverse Event Reporting System (FAERS) for the GLP-1 receptor agonists semaglutide (Ozempic/ Wegovy, Novo Nordisk), liraglutide, exenatide and dulaglutide (Trulicity, Eli Lilly) with cutaneous adverse event reports for the dipeptidyl peptidase-4 (DPP-IV) inhibitors sitagliptin, saxagliptin, linagliptin and alogliptin

The mechanism is to promote melanin synthesis by increasing the phosphorylation level of p38 MAPK, which in turn increases the expression of MITF and tyrosinase (Hirata et al., 2007)